Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-03

FDA Approved: TEMAZEPAM — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Temazepam from Ascend Laboratories, LLC, enabling a generic Temazepam product to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temazepam (Temazepam)

Snippet

SUPPL AP for TEMAZEPAM (TEMAZEPAM)